{"nct_id":"NCT03518086","title":"An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2018-06-18","start_date_type":"ACTUAL","primary_completion_date":"2021-01-21","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}